Background. The reliability of MUC2 as a prognostic marker in colorectal cancer (CRC) is
controversial. This study evaluated the association between MUC2 expression levels in …

Background Colorectal cancer is the third most commonly diagnosed malignancy and the
fourth leading cause of cancer-related death globally. It is the second most common cancer …

Background Despite the fact that tumor microenvironment (TME) and gene mutations are the
main determinants of progression of the deadliest cancer in the world–lung cancer, their …

Background: The presence of competing risks means that the results obtained using the
classic Cox proportional-hazards model for the factors affecting the prognosis of patients …

Objectives. Accumulating evidence indicates that the expression and/or variants of several
genes play an essential role in the progress of colorectal cancer (CRC). The current study is …

Background Colorectal cancer (CRC) is a major cause of cancer-related mortality
worldwide. It is the second leading cause of cancer death in men and women in Malaysia …

Objective This retrospective observational study aims to develop and validate artificial
intelligence (AI) pathomics models based on pathological Hematoxylin–Eosin (HE) slides …

Abstract Background PDE9A (Phosphodiesterase 9A) plays an important role in proliferation
of cells, their differentiation and apoptosis via intracellular cGMP (cyclic guanosine …

Background: Colorectal cancer (CRC) is the third most common cancer in both men and
women. In most Asian countries, both the incidence and mortality rates of CRC are gradually …

Colorectal cancer is one of the commonest cancer types that has a great public health
impact both in developed and developing countries. However, in Ethiopia, the survival status …